The Lancet Regional Health Europe in conversation with

Aida Perramon-Malavez and Antoni Soriano-Arandes on the real-world impact of nirsevimab

The Lancet Group

Can nirsevimab transform prevention strategies for respiratory infection in infants? Join Stephanie Becker as she sits down with Aida Perramon-Malavez and Antoni Soriano-Arandes to explore the significant threat that respiratory syncytial virus (RSV) poses to young children. 

Discover insights into the real-world impact of nirsevimab implementation during its first season, explore how prevention strategies vary across Europe, and hear about the urgent need for equitable access to vaccination worldwide.

Read the full article:

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00126-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanepe